Clinical guidelines for colorectal cancer include genetic testing and management of hereditary gastrointestinal cancer syndromes, as well as various treatment options and prognostic factors for stage III colon cancer. Studies also explore the use of circulating tumor DNA for predicting outcomes and tracking minimal residual disease in localized colon cancer.